3/22/2021

Grünenthal supports the public ambitions of the Contergan Foundation to facilitate an early payout of the remaining foundation capital to people affected by thalidomide. The exchange between Grünenthal and the affected parties made it clear that a larger, early payout now would make a greater contribution to improving their living situation than the annual special payments made to date.

12/14/2020

50 years ago today, the Aachen Regional Court terminated the Thalidomide proceedings against nine Grünenthal senior employees. The criminal trial is still considered one of the most complex and costly proceedings in German legal history. The legal and medical questions concerning the Thalidomide tragedy were complex and difficult to answer.

10/7/2020

Yesterday, the Australian Government has announced a programme to financially support people affected by thalidomide. The proposal has been prepared by the Minister of Health after a request from the senate in 2019.

6/24/2020

The German federal parliament adopted an amendment to the Contergan Foundation Act on 19 June 2020, whereby benefits to thalidomide victims, once granted, cannot be revoked. This includes the thalidomide pension, which is paid by the Contergan Foundation. Only in special cases, such as deliberate deception, is it possible to withdraw benefits.

7/1/2019

The pensions paid by the Contergan Foundation to people affected by thalidomide in Germany and abroad will be increased by 3.22 percent as of July 1, 2018.

7/1/2019

After more than 60 years, researchers at the renowned Dana-Farber Cancer Institute in Boston have succeeded in identifying the causes of thalidomide-induced congenital malformations.